Clinical Trials Logo

Cardiovascular Disease clinical trials

View clinical trials related to Cardiovascular Disease.

Filter by:

NCT ID: NCT02497950 Completed - Heart Failure Clinical Trials

HeartMate 3 ELEVATE™ Registry

ELEVATE™
Start date: October 13, 2015
Phase:
Study type: Observational [Patient Registry]

Evaluate real-world experience of HeartMate 3 (HM3) in post-approval setting.

NCT ID: NCT02496728 Completed - Clinical trials for Cardiovascular Disease

NUYou:mHealth Intervention to Preserve and Promote Ideal Cardiovascular Health

NUYou
Start date: May 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the preservation or promotion of health in students during the college years.

NCT ID: NCT02486913 Completed - Clinical trials for Cardiovascular Disease

Enhancing Diagnosis and Prevention of Cardiovascular Disease in Newham by Integrated Use of Electronic Health Records

Start date: August 2015
Phase: N/A
Study type: Interventional

The investigators will develop a "risk report" within the primary care electronic health record (EMIS) for patients attending for their National Health Service Health Check. The value of the report for reducing cardiovascular risk will be assessed qualitatively and also quantitatively in a non-randomised comparative trial.

NCT ID: NCT02479269 Completed - Clinical trials for Cardiovascular Disease

The Influence of Aerobic Exercise on Serum Brain Natriuretic Peptide and C- Reactive Protein in Cardiovascular Disease

AEBNPCRP
Start date: March 2015
Phase: N/A
Study type: Interventional

The purpose of this study was to investigate the effects of 8 weeks of aerobic exercise on serum concentrations of Brain Natriuretic Peptide and C - reactive protein in patients with cardiovascular disease. Patients were divided randomly into two groups: control and experimental aerobic group. This study was done with two - stage blood sampling: at the beginning and at the end of the treatment phase. All subjects were requested to avoid any exercise at least 48 hours before blood sampling. To study Brain Natriuretic Peptide and C - reactive protein changes, 5 milliliters of blood were taken from patient's brachial vein. Blood samples for subsequent measurements were frozen immediately and transported to the Hormone Laboratory for serum separation. The experimental group did the aerobic exercise programs for 8 weeks for 3 sessions per week and the control group did not receive any training. After completion of training, the final blood samplings were performed. Exercise intensity according to the heart rate remained stable until the last week. Brain Natriuretic Peptide and C - reactive protein levels were measured by ELISA tests. All statistical analysis were done using SPSS software (version 16) and at the significance level of p≤ 0.05

NCT ID: NCT02475460 Completed - Heart Failure Clinical Trials

HeartMate 3™ LIS Study

HM 3 LIS
Start date: May 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate a less invasive implantation technique of the HeartMate 3 Left Ventricular Assist System (HM 3 LVAS) in 10 patients.

NCT ID: NCT02464501 Completed - Clinical trials for Cardiovascular Disease

The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee

COPPER-A
Start date: May 20, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of paclitaxel administration using the occlusion perfusion catheter (OPC) for the prevention of restenosis in infrainguinal de novo, restenotic femoropopliteal and infrapopliteal stenoses and occlusions, and in-stent restenosis.

NCT ID: NCT02460211 Completed - Clinical trials for Cardiovascular Disease

Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D

ASSESS-D
Start date: July 2015
Phase: N/A
Study type: Interventional

Each patient who is admitted for preoperative preparation for elective open heart surgery at Intermountain Medical Center will be invited to participate in this study. After a written informed consent is obtained, patients meeting inclusion/exclusion criteria will be randomized 1:1 to the treatment arm or placebo/control arm. Those randomized to the treatment arm will receive three 50,000 unit oral doses of vitamin D3 supplementation. The first dose will be given the evening before surgery. The second and third doses will be given either orally or per NG tube on the mornings of post-op days 1 and 2. Blood will be obtained at the following time periods: 1) At baseline pre-procedure 12 to 18 hours before planned surgery; 2) Post-operative day 1, 12 to 24 hours after surgery; 3) 48 hours after surgery; 4) 72 hours after surgery; 5) At discharge (estimated to be between 5-8 days after surgery); and 6) At the 6-month follow-up visit (post-surgery). Plasma levels of 25(OH) vitamin D will be measured on each sample.

NCT ID: NCT02454127 Completed - Obesity Clinical Trials

Effectiveness of Four Popular Diet Strategies for Weight Loss and Cardiac Risk Reduction

Start date: July 2000
Phase: N/A
Study type: Interventional

A single-center randomized trial at an academic medical center in Boston, Mass, of overweight or obese (body mass index: mean, 35; range, 27-42) adults aged 22 to 72 years with known hypertension, dyslipidemia, or fasting hyperglycemia. Participants were enrolled starting July 18, 2000, and randomized to 4 popular diet groups until January 24, 2002.

NCT ID: NCT02445079 Completed - Hypertension Clinical Trials

Ugandan Non-Communicable Diseases and Aging Cohort

UGANDAC
Start date: December 2013
Phase:
Study type: Observational

Longitudinal cohort study of older-aged people living with HIV infection in southwestern Uganda and age and gender-matched HIV uninfected controls with the primary aim of measuring the epidemiology of cardiovascular and pulmonary disease in this study setting, and particularly the contribution of HIV infection to it.

NCT ID: NCT02428634 Completed - Clinical trials for Cardiovascular Disease

The Program SI! for Cardiovascular Health Promotion at Elementary School

PSIE
Start date: October 2014
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the effects of Program SI! for Elementary in different times of exposure for childrens and their immediate environment (teachers and parents). For this purpose, 48 public schools from the Community of Madrid-South Area (Spain) were randomly assigned to Program SI! during 3 or 6 academic years (intervention group) or keep their normal curriculum (control group). The main outcome is 3-year, and 6-year changes from baseline of questionnaire scoring of children, their parents and teachers in regards to a healthy lifestyle. For children were included 3-year, and 6-year changes of cardiovascular markers derived from blood pressure and anthropometry.